← Back to Clinical Trials
Recruiting NCT07147569

TAMBE Japan Post-Marketing Surveillance

Trial Parameters

Condition Thoracoabdominal Aortic Aneurysm
Sponsor W.L.Gore & Associates
Study Type OBSERVATIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2026-03-01
Completion 2034-02-28
Interventions
GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis

Brief Summary

To evaluate the safety and efficacy of multi component system (TAMBE device) including GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (Aortic Component; AC) under post-marketing use.

Eligibility Criteria

Inclusion Criteria: * Patients who were attempted to implant the AC * Thoracoabdominal aortic aneurysm * Pararenal abdominal aortic aneurysm Exclusion Criteria: * N/A

Related Trials